|
|
|
Volumn 22 Suppl 2, Issue , 2011, Pages
|
|
Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
MONOCLONAL ANTIBODY;
AGED;
ARTICLE;
CANCER STAGING;
CASE REPORT;
COLORECTAL TUMOR;
HUMAN;
PATHOLOGY;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
NEOPLASM STAGING;
TREATMENT OUTCOME;
|
|
EID: 84859908843
PISSN: None
EISSN: 14735741
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
